Hepatitis C is a viral infection that causes inflammation and damage to the liver, requiring a liver transplant if not ...

Hepatitis B and C infections represent the leading causes of liver cancer worldwide. These viruses gradually damage liver ...

On Friday, Vir Biotechnology, Inc. (NASDAQ:VIR) announced end-of-treatment data from Part B of the MARCH Phase 2 study ...

Hepatocellular carcinoma, a type of liver cancer, is the sixth most common cancer worldwide and the third leading cause of ...

Liver cancer is the sixth leading cause of cancer death in the U.S. The most common type of liver cancer in adults is ...

Hepatitis is inflammation and liver damage caused by various causes. This inflammation can be short-lived (Acute) or last for a long time (Chronic). Hepatitis can have multiple effects on the ...

the researchers sought to develop a better risk score for those patients who do not have viral hepatitis or cirrhosis. In the ...

Hepatitis C is a viral infection that causes liver inflammation, sometimes leading to serious liver damage. The infection can ...

Bilirubin, the byproduct of hemoprotein breakdown, particularly hemoglobin, is a critical marker in diagnosing, prognosing, ...

Acute-on-chronic liver failure (ACLF) is a life-threatening condition characterized by acute deterioration of liver function ...

This review discussed experimental mouse models used in the pre-clinical study of liver fibrosis regression, a pivotal ...

ASCEND-NASH is a Phase 2b, randomized, m EDISON, N.J., March 06, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on ...